As the only approved treatment to address disease progression, SKYCLARYS addresses a long-standing gap in the care of Canadians living with Friedreich’s ataxia Friedreich’s ataxia is a rare, progressive, debilitating… Read More
Final data analysis from Phase 3 MIRASOL trial after 30.5-month median follow-up demonstrated 32% reduction in risk of death with ELAHERE compared to chemotherapy in folate receptor alpha (FRα)-positive platinum-resistant… Read More
DELTA, BC – Phyton Biotech is pleased to announce a recent publication by iScience showcasing the successful application of its plant cell fermentation platform to derive an important compound. A compound traditionally… Read More
Congratulations to Karimah Es Sabar and Dr. Jason Acker on receiving the King Charles III Medal for their contributions to the life sciences community. GlycoNet is proud to congratulate two… Read More
SAINT JOHN, NB – Horizon Health Network (Horizon) and its New Brunswick Heart Centre, together with Amgen Canada Inc., are proud to announce a groundbreaking research project aimed at improving… Read More
